Tapazole · DIN 00015741 · 5 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2026-07-16 — choose a marketed DIN from the same-category list.Discontinued July 16, 2026 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-07-16 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-07-16 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Tapazole · DIN 00015741
Manufacturer: Knight Therapeutics Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2026-07-16 · brand TAPAZOLE · ATC H03BB02 THIAMAZOLE · form Tablet · route Oral · ingredients METHIMAZOLE 5 MG · company Knight therapeutics inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMinistry pays: $0.1531 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00015741)
Source record
DIN 00015741: Tapazole
Raw flags: sec3=Y
Item: 683800001; group id 808; item number 1985; lccId None; manufacturer id KNT
Source form: Tab; strength: 5mg
Recorded listing: General benefit
Source prices (unrounded): $0.3696; ministry $0.1531
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00015741
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9
Interchangeable products
Jamp Methimazole · DIN 02490625 · $0.1531
Mar-Methimazole · DIN 02480107 · $0.1531
Shortage status: active shortage (reported June 21, 2024, last updated June 22, 2024) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00015741
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 16, 2026 — choose a marketed DIN from the same-category list.